Search Results for 'genotype hcv'

genotype hcv published presentations and documents on DocSlides.

Table 4-1. Interpretation of hepatitis C laboratory results
Table 4-1. Interpretation of hepatitis C laboratory results
by bethany
Test. . Outcome*. Interpretation†. Further. . ...
Marion G. Peters, MD John V. Carbone, MD, Endowed Chair
Marion G. Peters, MD John V. Carbone, MD, Endowed Chair
by ashley
Professor of Medicine. Chief of Hepatology Researc...
SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1
SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1
by test
SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1 No...
ALLY-3 Design Objective SVR
ALLY-3 Design Objective SVR
by mitsue-stanley
12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...
Daclatasvir
Daclatasvir
by giovanna-bartolotta
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
Direct Acting Antivirals:  What are they?  What is their pl
Direct Acting Antivirals: What are they? What is their pl
by tawny-fly
Mark Sulkowski, MD. Associate Professor of Medici...
Boceprevir in Treatment Experienced
Boceprevir in Treatment Experienced
by tatiana-dople
RESPOND-2. Phase . 3. Treatment. . Experienced. ...
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PW
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PW
by ellena-manuel
G. . Ntetskas. , V. . Papastergiou. , L. . Skorda...
TURQUOISE-II
TURQUOISE-II
by pasty-toler
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Telaprevir in Treatment
Telaprevir in Treatment
by marina-yarberry
Naïve GT-1. ADVANCE (Study 108). Phase . 3. Trea...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by jane-oiler
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
Elbasvir-Grazoprevir
Elbasvir-Grazoprevir
by giovanna-bartolotta
. +/- Ribavirin in HCV Genotype 1, 4 or 6. C-EDG...
Sofosbuvir in
Sofosbuvir in
by giovanna-bartolotta
Genotype . 2. . or 3 . FUSION. Trial. Phase . ...
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
by debby-jeon
. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by trish-goza
in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...
HIV and viral hepatitis co-infection
HIV and viral hepatitis co-infection
by cheryl-pisano
Wirach Maek-a-nantawat, MD.. 11 July 2011. Conte...
Daclatasvir
Daclatasvir
by trish-goza
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir
Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir
by vamput
Prepared by: . Sophie . Woolston. , MD and David H...
≥ 18 years, HCV genotype 1-6
≥ 18 years, HCV genotype 1-6
by karlyn-bohler
≥ 18 years, HCV genotype 1-6 HCV RNA > 1 00...
CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE
CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE
by tawny-fly
ASSOC. PROF. DR. INGRID MIRON. What is Viral Hepa...
C-WORTHY/B
C-WORTHY/B
by stefany-barnette
Randomisation*. Open-label. >. 18 years. HCV ...
LDV/SOF
LDV/SOF
by conchita-marotz
Open-label. Chronic HCV infection. Genotype 1 . F...
Dore G. J
Dore G. J
by myesha-ticknor
Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...
Dore G. J
Dore G. J
by pasty-toler
Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...
SOF/VEL
SOF/VEL
by trish-goza
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
SIRIUS
SIRIUS
by tawny-fly
Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...
2014 hepatitis c support project 283868
2014 hepatitis c support project 283868
by pasty-toler
HCV Genotype, Quasispecies and Subtype HCSP FACT S...